Restricted accessResearch articleFirst published online 2012-5
The Pharmacists’ Role in the Patient-Centered Medical Home (PCMH) A white paper created by the Health Policy Committee of the Pennsylvania Pharmacists Association (PPA)
ErnstFR, GrizzleAJ. Drug-related morbidity and mortality: updating the cost-of-illness model. J Am Pharm Assoc. 2001; 41(2):192–9.
5.
MartinA, LassmanD, WhittleL. Recession contributes to slowest annual rate of increase in health spending in five decades. Health Aff. 2011; 30(1):11–22.
6.
BatesDW. Role of pharmacists in the medical home. Am J Health Syst Pharm. 2009; 66:1116–8.
7.
YamallKH, OstbyeT, KrauseKM. Family physicians as team leaders: “Time” to share the care. Prey Chronic Dis. 2009; 6(2):A59.
8.
BodenheimerT. Primary care - will it survive?N Engl J Med. 2006; 355(9):861–4.
9.
BodenheimerT, PhamH. Primary care: Current problems and proposed solutions. Health Aff. 2010; 29(5):799–805.
10.
FieldTS, GurwitzJH, HarroldLR. Risk Factors for adverse events among older adults in the ambulatory setting. J Am GeriatrSoc. 2004; 52(8):1349–54.
11.
ViktilKK, BlixHS, MogerTA. Polypharmacy as commonly defined is an indicator of limited value in the assessment of drug-related problems. Br J Clin Pharmacol. 2007; 63:187–95.
12.
KaufmanDW, KellyJP, RosenbergL. Recent patterns of medication use in the ambulatory adult population of the United States: the slone survey. JAMA2002; 287(3):337–344.
13.
BennerJS, GlynnRJ, MogunH. Long-term persistence in the use of statin therapy in elderly patients. JAMA2002; 288(4):455–61.
14.
CramerJ, RosenheckR, KirkG. Medication compliance feedback and monitoring in a clinical trial: predictors and outcomes. Value Health. 2003; 6(5):566–73.
15.
PetersonAM, TakiyaL, FinleyR. Meta-analysis of trials of interventions to improve medication adherence. Am J Health Syst Pharm. 2003; 60(7):657–65.
HeplerCD, StrandL. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990; 47:533–43.
26.
Chisholm-BurnsMA, LeeJK, SpiveyCA. US pharmacists’ effect as team members on patient care: systematic review and meta-analyses. Med Care. 2010; 48:923–933.
27.
BlumlB. Definition of medication therapy management: development of a profession wide consensus. J Am Pharm Assoc. 2005; 45(5):566–572.
The Lewin Group.Medication Therapy Management service: a critical review, www.pharmacist.com (accessed 2011 Nov 14).
32.
CarterBL, ArderyG, DawsonJD. Physician and pharmacist collaboration to improve blood pressure control. Arch Intern Med. 2009; 169:1996–2002.
33.
PonniahA, AndersonB, ShakibS. Pharmacists’ role in the post-discharge management of patients with heart failure: a literature review. J Clin Pharm Ther. 2007; 32(4):343–52.
34.
LeeJK, GraceKA, TaylorAJ. Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: a randomized controlled trial. JAMA. 2006; 296:2563–2571.
35.
Patient Centered Primary Care Collaborative 2010.Incorporating comprehensive medication management to optimize patient outcomes, http://www.pcpcc.net/files/medmanagepub.pdf (accessed 2011 Nov 14
36.
SmithM, BatesDW, BodenheimerT. Why pharmacists belong in the medical home. Health Aff. 2010; 29(5):906–913
Accreditation Council for Pharmacy Education.Accreditation standards and guidelines for the professional program in pharmacy leading to the doctor of pharmacy degree. Chicago, Illinois: Accreditation Council for Pharmacy Education;2011.
National Archives and Records Administration.Code of Federal Regulations: Title 42. Cost of approved nursing and allied health education activities. 42CFR413.85. § 413.85;2010.
Commission for Certification in Geriatric Pharmacy.Statement on pharmacy credentialing, quality assurance and medicare coverage of medication therapy management services. http://www.ccgp.org/links/Statement_Credentialing.pdf (accessed 2011 Nov 14).
KozminskiM, BusbyR, McGivneyMS. Pharmacist integration into the medical home: Qualitative analysis. J Am Pharm Assoc. 2011; 51(2):173–83.
49.
BerdineHJ, SkomoMG. The medical home: Development and integration of pharmacist clinical services into the patient-centered medical home. J Am Pharm Assoc. Accepted for publication 2012.
50.
Academy of Managed Care Pharmacy.Pharmacists as vital members of accountable care organizations: Illustrating the important role that pharmacists play on health care teams; 2011. www.amcp.org/aco.pdf (accessed 2011 Nov 14).
51.
CranorCW, BuntingBA, ChristensenDB. The asheville project: long term clinical and economic outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc. 2003; 43(2):173–84.
52.
BuntingBA, CranorCW. The asheville project: long-term clinical, humanistic, and economic outcomes of a community-based medication therapy management program for asthma. J Am Pharm Assoc. 2006; 46(2):133–47.
53.
BuntingBA, SmithBH, SutherlandSE. The asheville project: clinical and economic outcomes of a community-based medication therapy management program for hypertension and dyslipidemia. J Am Pharm Assoc. 2008; 48:23–31.
54.
MichaelsNM, JenkinsGF, PrussDL. Retrospective analysis of community pharmacists’ recommendations in the North Carolina Medicaid medication therapy management program. J Am Pharm Assoc. 2010; 50(3):347–53
55.
TrapskinK, JohnsonC, CoryP. Forging a novel provider and payer partnership in Wisconsin to compensate pharmacists for quality driven pharmacy and medication therapy management services. J Am Pharm Assoc. 2009; 49:642–651
56.
KripalaniS, LeFevreF, PhillipsCO. Deficits in communication and information transfer between hospital-based and primary care physicians: implications for patient safety and continuity of care. JAMA. 2007; 297(8):831–41.
57.
HammondRW, DoleEJ. The pharmacist clinician: prescriptive authority in New Mexico. J Manag Care Pharm. 1996; 2(5):594–596.
58.
HammondRW, SchwartzAH, CampbellMJ. ACCP position statement: Collaborative drug therapy management by pharmacists. Pharmacotherapy. 2003; 23(9):1210–25.
59.
StoneJ, HoffmanGJ. Medicare hospital readmissions: Issues, policy options, and PPACA. Congressional Research Service.Washington D.C.; 2010 Sep 21.
60.
ForsterAJ, MurffHJ, PetersonJF. The incidence and severity of adverse events affecting patients after discharge from the hospital. Ann Intern Med. 2003; 138(3):161–7.
61.
ColemanEA, SmithJD, RahaD, MinSJ. Post hospital medication discrepancies: prevalence and contributing factors. Arch Intern Med. 2005; 165(16):1842–7.
62.
American Society of Health-System Pharmacists Continuity of Care Task Force.Continuity of care in medication management: review of issues and considerations for pharmacy. Am J Health Syst Pharm. 2005; 62:1714–20.
63.
EllittGR, BrienJE, AsianiP. Quality patient care and pharmacists’ role in its continuity - A systematic review. Ann Pharmacotherapy. 2009; 43:677–91.
64.
GillespieU, AlassaadA, HenrohnD. A comprehensive pharmacist intervention to reduce morbidity in patients 80 years or older: a randomized controlled trial. Arch Intern Med. 2009; 169:894–900.
65.
IsettsBJ, SchondelmeyerSW, ArtzMB. Clinical and economic outcomes of medication therapy management services: The Minnesota experience. J Am Pharm Assoc. 2008; 48:203–11.
66.
CipolleR, StrandL, MorleyP. Pharmaceutical care practice: The clinician's guide. McGraw-Hill; 2004.
LandonBE, GillJM, AntonelliRC. Prospects for rebuilding primary care using the patient-centered medical home. Health Affairs. 2010; 29:827–34.
69.
LounsberyJL, GreenCG, BennettMS. Evaluation of pharmacists’ barriers to the implementation of medication therapy management services. J Am Pharm Assoc. 2009; 49:51–8.
70.
CookDM, Mburia-MwaliliA. Medication therapy management favors large pharmacy chains and creates potential conflicts of interest. J Manag Care Pharm. 2009; 15:495–500.
